# Clementia Pharmaceuticals Inc.: Form D filing

Clementia Pharmaceuticals Inc., a pharmaceuticals company in Dorval, Quebec, Canada, filed a Form D with the SEC in 2015. The latest, on July 7, 2015, reports $60 million sold of a $60 million offering to 16 investors.

Find out what Clementia Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Clementia%20Pharmaceuticals%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Clementia%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fclementia-pharmaceuticals-inc-1647320)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Clementia%20Pharmaceuticals%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Clementia%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fclementia-pharmaceuticals-inc-1647320)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1375 TRANS-CANADA HIGHWAY, SUITE 200, Dorval, Quebec, Canada, H9P 2
- Phone: (514) 940-3600
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Canada (Federal Level)
- Year incorporated: 2010
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1647320

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 7, 2015 | New notice | $59,999,141 | $59,999,141 | $0 | 16 | Jun 22, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1647320/000093041315003024/0000930413-15-003024-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Francois P. Nader | Director |  |
| Donna Roy Grogan | Executive Officer |  |
| Jean-Francois P. Pariseau | Executive Officer, Director |  |
| Michael Roy Singer | Executive Officer |  |
| David P. Bonita | Director |  |
| Robert P. Heft | Director |  |
| Clarissa Desjardins | Executive Officer, Director |  |
| Eric P. Grinstead | Executive Officer |  |
| Jeffrey Roy Packman | Executive Officer |  |
| Allan P. Mandelzys | Director |  |

[Every Form D from the week of Jul 6, 2015](https://specstream.ai/data/form-d/week/2015-07-06) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Clementia Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).